img

Global Biotechnological Drugs Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global Biotechnological Drugs Market Insights, Forecast to 2034

Biotechnological Drugs, also known as biologics, are pharmaceutical products derived from living organisms using biotechnology techniques. These drugs can include vaccines, monoclonal antibodies, and gene therapies.
Market Analysis and InsightsGlobal Biotechnological Drugs Market
Global Biotechnological Drugs market is expected to reach to US$ million in 2023, with a positive growth of %, compared with US$ million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Biotechnological Drugs industry is evaluated to reach US$ million in 2033. The CAGR will be % during 2023 to 2033.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers
This report presents an overview of global Biotechnological Drugs market from 2018 to 2033, aiming to help readers to get a comprehensive understanding of global Biotechnological Drugs market with multiple angles. Items like regional revenue from 2018 to 2033 and companies’ revenue and gross margin from 2018 to 2023 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2033 are also highlighted.
Companies, Type, Application and Regions Listed in the Report



By Company


3SBIO
Anhui Anke Biotechnology
Beijing SL Pharmaceutical
Biotech Pharmaceutical
Cadila Healthcare
Celgen Biopharma
Celltrion
Dr Reddy’s
GeneScience Pharmaceuticals
Hisun Pharma
Jiangsu Sihuan Bioengineering
Novartis (Sandoz)
Pfizer (Hospira)
Shanghai Lansheng Guojian Pharmaceutical
Shenzhen Neptunus Interlong Bio-Technique
Tonghua Dongbao Pharmaceutical
Torrent Pharmaceuticals
Segment by Type
Genetically Engineered Drugs
Therapeutic Monoclonal Antibody Drugs
Gene Therapy and Nucleic Acid Drugs
Genetically Engineered Vaccines
Other

Segment by Application


Tumor
Autoimmune Disease
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2033
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2033 globally
Chapter 5Product revenue analysis by application from 2018 to 2033 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2033 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2033
Chapter 7Product revenue analysis by type and application from 2018 to 2033 in Europe. Product revenue analysis of each country in Europe from 2018 to 2033
Chapter 8Product revenue analysis by type and application from 2018 to 2033 in China. Product revenue analysis of China from 2018 to 2033
Chapter 9Product revenue analysis by type and application from 2018 to 2033 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2033
Chapter 10Product revenue analysis by type and application from 2018 to 2033 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2033.
Chapter 11Companies’ outline, covering company’s basic information, major business, Biotechnological Drugs introduction, etc. Biotechnological Drugs Revenue and Gross Margin of each company from 2018 to 2023
Chapter 12MRAResearch’s Conclusions of Biotechnological Drugs
Chapter 13Methodology and Data Sources adopted by MRAResearch

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Biotechnological Drugs Market Size Growth Rate by Type, 2018 VS 2022 VS 2033
1.2.2 Genetically Engineered Drugs
1.2.3 Therapeutic Monoclonal Antibody Drugs
1.2.4 Gene Therapy and Nucleic Acid Drugs
1.2.5 Genetically Engineered Vaccines
1.2.6 Other
1.3 Market by Application
1.3.1 Global Biotechnological Drugs Market Size Growth Rate by Application, 2018 VS 2022 VS 2033
1.3.2 Tumor
1.3.3 Autoimmune Disease
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Biotechnological Drugs Market Perspective (2018-2033)
2.2 Global Biotechnological Drugs Growth Trends by Region
2.2.1 Biotechnological Drugs Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Biotechnological Drugs Historic Market Size by Region (2018-2023)
2.2.3 Biotechnological Drugs Forecasted Market Size by Region (2024-2033)
2.3 Biotechnological Drugs Market Dynamics
2.3.1 Biotechnological Drugs Industry Trends
2.3.2 Biotechnological Drugs Market Drivers
2.3.3 Biotechnological Drugs Market Challenges
2.3.4 Biotechnological Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Biotechnological Drugs by Players
3.1.1 Global Biotechnological Drugs Revenue by Players (2018-2023)
3.1.2 Global Biotechnological Drugs Revenue Market Share by Players (2018-2023)
3.2 Global Biotechnological Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Biotechnological Drugs, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Biotechnological Drugs Market Concentration Ratio
3.4.1 Global Biotechnological Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Biotechnological Drugs Revenue in 2022
3.5 Global Key Players of Biotechnological Drugs Head office and Area Served
3.6 Global Key Players of Biotechnological Drugs, Product and Application
3.7 Global Key Players of Biotechnological Drugs, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Biotechnological Drugs Breakdown Data by Type
4.1 Global Biotechnological Drugs Historic Market Size by Type (2018-2023)
4.2 Global Biotechnological Drugs Forecasted Market Size by Type (2024-2033)
5 Biotechnological Drugs Breakdown Data by Application
5.1 Global Biotechnological Drugs Historic Market Size by Application (2018-2023)
5.2 Global Biotechnological Drugs Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Biotechnological Drugs Market Size (2018-2033)
6.2 North America Biotechnological Drugs Market Size by Type
6.2.1 North America Biotechnological Drugs Market Size by Type (2018-2023)
6.2.2 North America Biotechnological Drugs Market Size by Type (2024-2033)
6.2.3 North America Biotechnological Drugs Market Share by Type (2018-2033)
6.3 North America Biotechnological Drugs Market Size by Application
6.3.1 North America Biotechnological Drugs Market Size by Application (2018-2023)
6.3.2 North America Biotechnological Drugs Market Size by Application (2024-2033)
6.3.3 North America Biotechnological Drugs Market Share by Application (2018-2033)
6.4 North America Biotechnological Drugs Market Size by Country
6.4.1 North America Biotechnological Drugs Market Size by Country: 2018 VS 2022 VS 2033
6.4.2 North America Biotechnological Drugs Market Size by Country (2018-2023)
6.4.3 North America Biotechnological Drugs Market Size by Country (2024-2033)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Biotechnological Drugs Market Size (2018-2033)
7.2 Europe Biotechnological Drugs Market Size by Type
7.2.1 Europe Biotechnological Drugs Market Size by Type (2018-2023)
7.2.2 Europe Biotechnological Drugs Market Size by Type (2024-2033)
7.2.3 Europe Biotechnological Drugs Market Share by Type (2018-2033)
7.3 Europe Biotechnological Drugs Market Size by Application
7.3.1 Europe Biotechnological Drugs Market Size by Application (2018-2023)
7.3.2 Europe Biotechnological Drugs Market Size by Application (2024-2033)
7.3.3 Europe Biotechnological Drugs Market Share by Application (2018-2033)
7.4 Europe Biotechnological Drugs Market Size by Country
7.4.1 Europe Biotechnological Drugs Market Size by Country: 2018 VS 2022 VS 2033
7.4.2 Europe Biotechnological Drugs Market Size by Country (2018-2023)
7.4.3 Europe Biotechnological Drugs Market Size by Country (2024-2033)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Biotechnological Drugs Market Size (2018-2033)
8.2 China Biotechnological Drugs Market Size by Type
8.2.1 China Biotechnological Drugs Market Size by Type (2018-2023)
8.2.2 China Biotechnological Drugs Market Size by Type (2024-2033)
8.2.3 China Biotechnological Drugs Market Share by Type (2018-2033)
8.3 China Biotechnological Drugs Market Size by Application
8.3.1 China Biotechnological Drugs Market Size by Application (2018-2023)
8.3.2 China Biotechnological Drugs Market Size by Application (2024-2033)
8.3.3 China Biotechnological Drugs Market Share by Application (2018-2033)
9 Asia (excluding China)
9.1 Asia Biotechnological Drugs Market Size (2018-2033)
9.2 Asia Biotechnological Drugs Market Size by Type
9.2.1 Asia Biotechnological Drugs Market Size by Type (2018-2023)
9.2.2 Asia Biotechnological Drugs Market Size by Type (2024-2033)
9.2.3 Asia Biotechnological Drugs Market Share by Type (2018-2033)
9.3 Asia Biotechnological Drugs Market Size by Application
9.3.1 Asia Biotechnological Drugs Market Size by Application (2018-2023)
9.3.2 Asia Biotechnological Drugs Market Size by Application (2024-2033)
9.3.3 Asia Biotechnological Drugs Market Share by Application (2018-2033)
9.4 Asia Biotechnological Drugs Market Size by Region
9.4.1 Asia Biotechnological Drugs Market Size by Region: 2018 VS 2022 VS 2033
9.4.2 Asia Biotechnological Drugs Market Size by Region (2018-2023)
9.4.3 Asia Biotechnological Drugs Market Size by Region (2024-2033)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Biotechnological Drugs Market Size (2018-2033)
10.2 Middle East, Africa, and Latin America Biotechnological Drugs Market Size by Type
10.2.1 Middle East, Africa, and Latin America Biotechnological Drugs Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Biotechnological Drugs Market Size by Type (2024-2033)
10.2.3 Middle East, Africa, and Latin America Biotechnological Drugs Market Share by Type (2018-2033)
10.3 Middle East, Africa, and Latin America Biotechnological Drugs Market Size by Application
10.3.1 Middle East, Africa, and Latin America Biotechnological Drugs Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Biotechnological Drugs Market Size by Application (2024-2033)
10.3.3 Middle East, Africa, and Latin America Biotechnological Drugs Market Share by Application (2018-2033)
10.4 Middle East, Africa, and Latin America Biotechnological Drugs Market Size by Country
10.4.1 Middle East, Africa, and Latin America Biotechnological Drugs Market Size by Country: 2018 VS 2022 VS 2033
10.4.2 Middle East, Africa, and Latin America Biotechnological Drugs Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Biotechnological Drugs Market Size by Country (2024-2033)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 3SBIO
11.1.1 3SBIO Company Details
11.1.2 3SBIO Business Overview
11.1.3 3SBIO Biotechnological Drugs Introduction
11.1.4 3SBIO Revenue in Biotechnological Drugs Business (2018-2023)
11.1.5 3SBIO Recent Developments
11.2 Anhui Anke Biotechnology
11.2.1 Anhui Anke Biotechnology Company Details
11.2.2 Anhui Anke Biotechnology Business Overview
11.2.3 Anhui Anke Biotechnology Biotechnological Drugs Introduction
11.2.4 Anhui Anke Biotechnology Revenue in Biotechnological Drugs Business (2018-2023)
11.2.5 Anhui Anke Biotechnology Recent Developments
11.3 Beijing SL Pharmaceutical
11.3.1 Beijing SL Pharmaceutical Company Details
11.3.2 Beijing SL Pharmaceutical Business Overview
11.3.3 Beijing SL Pharmaceutical Biotechnological Drugs Introduction
11.3.4 Beijing SL Pharmaceutical Revenue in Biotechnological Drugs Business (2018-2023)
11.3.5 Beijing SL Pharmaceutical Recent Developments
11.4 Biotech Pharmaceutical
11.4.1 Biotech Pharmaceutical Company Details
11.4.2 Biotech Pharmaceutical Business Overview
11.4.3 Biotech Pharmaceutical Biotechnological Drugs Introduction
11.4.4 Biotech Pharmaceutical Revenue in Biotechnological Drugs Business (2018-2023)
11.4.5 Biotech Pharmaceutical Recent Developments
11.5 Cadila Healthcare
11.5.1 Cadila Healthcare Company Details
11.5.2 Cadila Healthcare Business Overview
11.5.3 Cadila Healthcare Biotechnological Drugs Introduction
11.5.4 Cadila Healthcare Revenue in Biotechnological Drugs Business (2018-2023)
11.5.5 Cadila Healthcare Recent Developments
11.6 Celgen Biopharma
11.6.1 Celgen Biopharma Company Details
11.6.2 Celgen Biopharma Business Overview
11.6.3 Celgen Biopharma Biotechnological Drugs Introduction
11.6.4 Celgen Biopharma Revenue in Biotechnological Drugs Business (2018-2023)
11.6.5 Celgen Biopharma Recent Developments
11.7 Celltrion
11.7.1 Celltrion Company Details
11.7.2 Celltrion Business Overview
11.7.3 Celltrion Biotechnological Drugs Introduction
11.7.4 Celltrion Revenue in Biotechnological Drugs Business (2018-2023)
11.7.5 Celltrion Recent Developments
11.8 Dr Reddy’s
11.8.1 Dr Reddy’s Company Details
11.8.2 Dr Reddy’s Business Overview
11.8.3 Dr Reddy’s Biotechnological Drugs Introduction
11.8.4 Dr Reddy’s Revenue in Biotechnological Drugs Business (2018-2023)
11.8.5 Dr Reddy’s Recent Developments
11.9 GeneScience Pharmaceuticals
11.9.1 GeneScience Pharmaceuticals Company Details
11.9.2 GeneScience Pharmaceuticals Business Overview
11.9.3 GeneScience Pharmaceuticals Biotechnological Drugs Introduction
11.9.4 GeneScience Pharmaceuticals Revenue in Biotechnological Drugs Business (2018-2023)
11.9.5 GeneScience Pharmaceuticals Recent Developments
11.10 Hisun Pharma
11.10.1 Hisun Pharma Company Details
11.10.2 Hisun Pharma Business Overview
11.10.3 Hisun Pharma Biotechnological Drugs Introduction
11.10.4 Hisun Pharma Revenue in Biotechnological Drugs Business (2018-2023)
11.10.5 Hisun Pharma Recent Developments
11.11 Jiangsu Sihuan Bioengineering
11.11.1 Jiangsu Sihuan Bioengineering Company Details
11.11.2 Jiangsu Sihuan Bioengineering Business Overview
11.11.3 Jiangsu Sihuan Bioengineering Biotechnological Drugs Introduction
11.11.4 Jiangsu Sihuan Bioengineering Revenue in Biotechnological Drugs Business (2018-2023)
11.11.5 Jiangsu Sihuan Bioengineering Recent Developments
11.12 Novartis (Sandoz)
11.12.1 Novartis (Sandoz) Company Details
11.12.2 Novartis (Sandoz) Business Overview
11.12.3 Novartis (Sandoz) Biotechnological Drugs Introduction
11.12.4 Novartis (Sandoz) Revenue in Biotechnological Drugs Business (2018-2023)
11.12.5 Novartis (Sandoz) Recent Developments
11.13 Pfizer (Hospira)
11.13.1 Pfizer (Hospira) Company Details
11.13.2 Pfizer (Hospira) Business Overview
11.13.3 Pfizer (Hospira) Biotechnological Drugs Introduction
11.13.4 Pfizer (Hospira) Revenue in Biotechnological Drugs Business (2018-2023)
11.13.5 Pfizer (Hospira) Recent Developments
11.14 Shanghai Lansheng Guojian Pharmaceutical
11.14.1 Shanghai Lansheng Guojian Pharmaceutical Company Details
11.14.2 Shanghai Lansheng Guojian Pharmaceutical Business Overview
11.14.3 Shanghai Lansheng Guojian Pharmaceutical Biotechnological Drugs Introduction
11.14.4 Shanghai Lansheng Guojian Pharmaceutical Revenue in Biotechnological Drugs Business (2018-2023)
11.14.5 Shanghai Lansheng Guojian Pharmaceutical Recent Developments
11.15 Shenzhen Neptunus Interlong Bio-Technique
11.15.1 Shenzhen Neptunus Interlong Bio-Technique Company Details
11.15.2 Shenzhen Neptunus Interlong Bio-Technique Business Overview
11.15.3 Shenzhen Neptunus Interlong Bio-Technique Biotechnological Drugs Introduction
11.15.4 Shenzhen Neptunus Interlong Bio-Technique Revenue in Biotechnological Drugs Business (2018-2023)
11.15.5 Shenzhen Neptunus Interlong Bio-Technique Recent Developments
11.16 Tonghua Dongbao Pharmaceutical
11.16.1 Tonghua Dongbao Pharmaceutical Company Details
11.16.2 Tonghua Dongbao Pharmaceutical Business Overview
11.16.3 Tonghua Dongbao Pharmaceutical Biotechnological Drugs Introduction
11.16.4 Tonghua Dongbao Pharmaceutical Revenue in Biotechnological Drugs Business (2018-2023)
11.16.5 Tonghua Dongbao Pharmaceutical Recent Developments
11.17 Torrent Pharmaceuticals
11.17.1 Torrent Pharmaceuticals Company Details
11.17.2 Torrent Pharmaceuticals Business Overview
11.17.3 Torrent Pharmaceuticals Biotechnological Drugs Introduction
11.17.4 Torrent Pharmaceuticals Revenue in Biotechnological Drugs Business (2018-2023)
11.17.5 Torrent Pharmaceuticals Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Biotechnological Drugs Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2033
Table 2. Key Players of Genetically Engineered Drugs
Table 3. Key Players of Therapeutic Monoclonal Antibody Drugs
Table 4. Key Players of Gene Therapy and Nucleic Acid Drugs
Table 5. Key Players of Genetically Engineered Vaccines
Table 6. Key Players of Other
Table 7. Global Biotechnological Drugs Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2033
Table 8. Global Biotechnological Drugs Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 9. Global Biotechnological Drugs Market Size by Region (2018-2023) & (US$ Million)
Table 10. Global Biotechnological Drugs Market Share by Region (2018-2023)
Table 11. Global Biotechnological Drugs Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 12. Global Biotechnological Drugs Market Share by Region (2024-2033)
Table 13. Biotechnological Drugs Market Trends
Table 14. Biotechnological Drugs Market Drivers
Table 15. Biotechnological Drugs Market Challenges
Table 16. Biotechnological Drugs Market Restraints
Table 17. Global Biotechnological Drugs Revenue by Players (2018-2023) & (US$ Million)
Table 18. Global Biotechnological Drugs Revenue Share by Players (2018-2023)
Table 19. Global Top Biotechnological Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biotechnological Drugs as of 2022)
Table 20. Global Biotechnological Drugs Industry Ranking 2021 VS 2022 VS 2023
Table 21. Global 5 Largest Players Market Share by Biotechnological Drugs Revenue (CR5 and HHI) & (2018-2023)
Table 22. Global Key Players of Biotechnological Drugs, Headquarters and Area Served
Table 23. Global Key Players of Biotechnological Drugs, Product and Application
Table 24. Global Key Players of Biotechnological Drugs, Product and Application
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Biotechnological Drugs Market Size by Type (2018-2023) & (US$ Million)
Table 27. Global Biotechnological Drugs Revenue Market Share by Type (2018-2023)
Table 28. Global Biotechnological Drugs Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 29. Global Biotechnological Drugs Revenue Market Share by Type (2024-2033)
Table 30. Global Biotechnological Drugs Market Size by Application (2018-2023) & (US$ Million)
Table 31. Global Biotechnological Drugs Revenue Share by Application (2018-2023)
Table 32. Global Biotechnological Drugs Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 33. Global Biotechnological Drugs Revenue Share by Application (2024-2033)
Table 34. North America Biotechnological Drugs Market Size by Type (2018-2023) & (US$ Million)
Table 35. North America Biotechnological Drugs Market Size by Type (2024-2033) & (US$ Million)
Table 36. North America Biotechnological Drugs Market Size by Application (2018-2023) & (US$ Million)
Table 37. North America Biotechnological Drugs Market Size by Application (2024-2033) & (US$ Million)
Table 38. North America Biotechnological Drugs Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 39. North America Biotechnological Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 40. North America Biotechnological Drugs Market Size by Country (2024-2033) & (US$ Million)
Table 41. Europe Biotechnological Drugs Market Size by Type (2018-2023) & (US$ Million)
Table 42. Europe Biotechnological Drugs Market Size by Type (2024-2033) & (US$ Million)
Table 43. Europe Biotechnological Drugs Market Size by Application (2018-2023) & (US$ Million)
Table 44. Europe Biotechnological Drugs Market Size by Application (2024-2033) & (US$ Million)
Table 45. Europe Biotechnological Drugs Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 46. Europe Biotechnological Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 47. Europe Biotechnological Drugs Market Size by Country (2024-2033) & (US$ Million)
Table 48. China Biotechnological Drugs Market Size by Type (2018-2023) & (US$ Million)
Table 49. China Biotechnological Drugs Market Size by Type (2024-2033) & (US$ Million)
Table 50. China Biotechnological Drugs Market Size by Application (2018-2023) & (US$ Million)
Table 51. China Biotechnological Drugs Market Size by Application (2024-2033) & (US$ Million)
Table 52. Asia Biotechnological Drugs Market Size by Type (2018-2023) & (US$ Million)
Table 53. Asia Biotechnological Drugs Market Size by Type (2024-2033) & (US$ Million)
Table 54. Asia Biotechnological Drugs Market Size by Application (2018-2023) & (US$ Million)
Table 55. Asia Biotechnological Drugs Market Size by Application (2024-2033) & (US$ Million)
Table 56. Asia Biotechnological Drugs Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 57. Asia Biotechnological Drugs Market Size by Region (2018-2023) & (US$ Million)
Table 58. Asia Biotechnological Drugs Market Size by Region (2024-2033) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Biotechnological Drugs Market Size by Type (2018-2023) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Biotechnological Drugs Market Size by Type (2024-2033) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Biotechnological Drugs Market Size by Application (2018-2023) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Biotechnological Drugs Market Size by Application (2024-2033) & (US$ Million)
Table 63. Middle East, Africa, and Latin America Biotechnological Drugs Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 64. Middle East, Africa, and Latin America Biotechnological Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 65. Middle East, Africa, and Latin America Biotechnological Drugs Market Size by Country (2024-2033) & (US$ Million)
Table 66. 3SBIO Company Details
Table 67. 3SBIO Business Overview
Table 68. 3SBIO Biotechnological Drugs Product
Table 69. 3SBIO Revenue in Biotechnological Drugs Business (2018-2023) & (US$ Million)
Table 70. 3SBIO Recent Developments
Table 71. Anhui Anke Biotechnology Company Details
Table 72. Anhui Anke Biotechnology Business Overview
Table 73. Anhui Anke Biotechnology Biotechnological Drugs Product
Table 74. Anhui Anke Biotechnology Revenue in Biotechnological Drugs Business (2018-2023) & (US$ Million)
Table 75. Anhui Anke Biotechnology Recent Developments
Table 76. Beijing SL Pharmaceutical Company Details
Table 77. Beijing SL Pharmaceutical Business Overview
Table 78. Beijing SL Pharmaceutical Biotechnological Drugs Product
Table 79. Beijing SL Pharmaceutical Revenue in Biotechnological Drugs Business (2018-2023) & (US$ Million)
Table 80. Beijing SL Pharmaceutical Recent Developments
Table 81. Biotech Pharmaceutical Company Details
Table 82. Biotech Pharmaceutical Business Overview
Table 83. Biotech Pharmaceutical Biotechnological Drugs Product
Table 84. Biotech Pharmaceutical Revenue in Biotechnological Drugs Business (2018-2023) & (US$ Million)
Table 85. Biotech Pharmaceutical Recent Developments
Table 86. Cadila Healthcare Company Details
Table 87. Cadila Healthcare Business Overview
Table 88. Cadila Healthcare Biotechnological Drugs Product
Table 89. Cadila Healthcare Revenue in Biotechnological Drugs Business (2018-2023) & (US$ Million)
Table 90. Cadila Healthcare Recent Developments
Table 91. Celgen Biopharma Company Details
Table 92. Celgen Biopharma Business Overview
Table 93. Celgen Biopharma Biotechnological Drugs Product
Table 94. Celgen Biopharma Revenue in Biotechnological Drugs Business (2018-2023) & (US$ Million)
Table 95. Celgen Biopharma Recent Developments
Table 96. Celltrion Company Details
Table 97. Celltrion Business Overview
Table 98. Celltrion Biotechnological Drugs Product
Table 99. Celltrion Revenue in Biotechnological Drugs Business (2018-2023) & (US$ Million)
Table 100. Celltrion Recent Developments
Table 101. Dr Reddy’s Company Details
Table 102. Dr Reddy’s Business Overview
Table 103. Dr Reddy’s Biotechnological Drugs Product
Table 104. Dr Reddy’s Revenue in Biotechnological Drugs Business (2018-2023) & (US$ Million)
Table 105. Dr Reddy’s Recent Developments
Table 106. GeneScience Pharmaceuticals Company Details
Table 107. GeneScience Pharmaceuticals Business Overview
Table 108. GeneScience Pharmaceuticals Biotechnological Drugs Product
Table 109. GeneScience Pharmaceuticals Revenue in Biotechnological Drugs Business (2018-2023) & (US$ Million)
Table 110. GeneScience Pharmaceuticals Recent Developments
Table 111. Hisun Pharma Company Details
Table 112. Hisun Pharma Business Overview
Table 113. Hisun Pharma Biotechnological Drugs Product
Table 114. Hisun Pharma Revenue in Biotechnological Drugs Business (2018-2023) & (US$ Million)
Table 115. Hisun Pharma Recent Developments
Table 116. Jiangsu Sihuan Bioengineering Company Details
Table 117. Jiangsu Sihuan Bioengineering Business Overview
Table 118. Jiangsu Sihuan Bioengineering Biotechnological Drugs Product
Table 119. Jiangsu Sihuan Bioengineering Revenue in Biotechnological Drugs Business (2018-2023) & (US$ Million)
Table 120. Jiangsu Sihuan Bioengineering Recent Developments
Table 121. Novartis (Sandoz) Company Details
Table 122. Novartis (Sandoz) Business Overview
Table 123. Novartis (Sandoz) Biotechnological Drugs Product
Table 124. Novartis (Sandoz) Revenue in Biotechnological Drugs Business (2018-2023) & (US$ Million)
Table 125. Novartis (Sandoz) Recent Developments
Table 126. Pfizer (Hospira) Company Details
Table 127. Pfizer (Hospira) Business Overview
Table 128. Pfizer (Hospira) Biotechnological Drugs Product
Table 129. Pfizer (Hospira) Revenue in Biotechnological Drugs Business (2018-2023) & (US$ Million)
Table 130. Pfizer (Hospira) Recent Developments
Table 131. Shanghai Lansheng Guojian Pharmaceutical Company Details
Table 132. Shanghai Lansheng Guojian Pharmaceutical Business Overview
Table 133. Shanghai Lansheng Guojian Pharmaceutical Biotechnological Drugs Product
Table 134. Shanghai Lansheng Guojian Pharmaceutical Revenue in Biotechnological Drugs Business (2018-2023) & (US$ Million)
Table 135. Shanghai Lansheng Guojian Pharmaceutical Recent Developments
Table 136. Shenzhen Neptunus Interlong Bio-Technique Company Details
Table 137. Shenzhen Neptunus Interlong Bio-Technique Business Overview
Table 138. Shenzhen Neptunus Interlong Bio-Technique Biotechnological Drugs Product
Table 139. Shenzhen Neptunus Interlong Bio-Technique Revenue in Biotechnological Drugs Business (2018-2023) & (US$ Million)
Table 140. Shenzhen Neptunus Interlong Bio-Technique Recent Developments
Table 141. Tonghua Dongbao Pharmaceutical Company Details
Table 142. Tonghua Dongbao Pharmaceutical Business Overview
Table 143. Tonghua Dongbao Pharmaceutical Biotechnological Drugs Product
Table 144. Tonghua Dongbao Pharmaceutical Revenue in Biotechnological Drugs Business (2018-2023) & (US$ Million)
Table 145. Tonghua Dongbao Pharmaceutical Recent Developments
Table 146. Torrent Pharmaceuticals Company Details
Table 147. Torrent Pharmaceuticals Business Overview
Table 148. Torrent Pharmaceuticals Biotechnological Drugs Product
Table 149. Torrent Pharmaceuticals Revenue in Biotechnological Drugs Business (2018-2023) & (US$ Million)
Table 150. Torrent Pharmaceuticals Recent Developments
Table 151. Research Programs/Design for This Report
Table 152. Key Data Information from Secondary Sources
Table 153. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Biotechnological Drugs Market Size Growth Rate by Type, 2018 VS 2022 VS 2033 (US$ Million)
Figure 2. Global Biotechnological Drugs Market Share by Type: 2022 VS 2033
Figure 3. Genetically Engineered Drugs Features
Figure 4. Therapeutic Monoclonal Antibody Drugs Features
Figure 5. Gene Therapy and Nucleic Acid Drugs Features
Figure 6. Genetically Engineered Vaccines Features
Figure 7. Other Features
Figure 8. Global Biotechnological Drugs Market Size Growth Rate by Application, 2018 VS 2022 VS 2033 (US$ Million)
Figure 9. Global Biotechnological Drugs Market Share by Application: 2022 VS 2033
Figure 10. Tumor Case Studies
Figure 11. Autoimmune Disease Case Studies
Figure 12. Other Case Studies
Figure 13. Biotechnological Drugs Report Years Considered
Figure 14. Global Biotechnological Drugs Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 15. Global Biotechnological Drugs Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 16. Global Biotechnological Drugs Market Share by Region: 2022 VS 2033
Figure 17. Global Biotechnological Drugs Market Share by Players in 2022
Figure 18. Global Top Biotechnological Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biotechnological Drugs as of 2022)
Figure 19. The Top 10 and 5 Players Market Share by Biotechnological Drugs Revenue in 2022
Figure 20. North America Biotechnological Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 21. North America Biotechnological Drugs Market Share by Type (2018-2033)
Figure 22. North America Biotechnological Drugs Market Share by Application (2018-2033)
Figure 23. North America Biotechnological Drugs Market Share by Country (2018-2033)
Figure 24. United States Biotechnological Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. Canada Biotechnological Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. Europe Biotechnological Drugs Market Size YoY (2018-2033) & (US$ Million)
Figure 27. Europe Biotechnological Drugs Market Share by Type (2018-2033)
Figure 28. Europe Biotechnological Drugs Market Share by Application (2018-2033)
Figure 29. Europe Biotechnological Drugs Market Share by Country (2018-2033)
Figure 30. Germany Biotechnological Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. France Biotechnological Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. U.K. Biotechnological Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Italy Biotechnological Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Russia Biotechnological Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. Nordic Countries Biotechnological Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. China Biotechnological Drugs Market Size YoY (2018-2033) & (US$ Million)
Figure 37. China Biotechnological Drugs Market Share by Type (2018-2033)
Figure 38. China Biotechnological Drugs Market Share by Application (2018-2033)
Figure 39. Asia Biotechnological Drugs Market Size YoY (2018-2033) & (US$ Million)
Figure 40. Asia Biotechnological Drugs Market Share by Type (2018-2033)
Figure 41. Asia Biotechnological Drugs Market Share by Application (2018-2033)
Figure 42. Asia Biotechnological Drugs Market Share by Region (2018-2033)
Figure 43. Japan Biotechnological Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. South Korea Biotechnological Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. China Taiwan Biotechnological Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Southeast Asia Biotechnological Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. India Biotechnological Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 48. Australia Biotechnological Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 49. Middle East, Africa, and Latin America Biotechnological Drugs Market Size YoY (2018-2033) & (US$ Million)
Figure 50. Middle East, Africa, and Latin America Biotechnological Drugs Market Share by Type (2018-2033)
Figure 51. Middle East, Africa, and Latin America Biotechnological Drugs Market Share by Application (2018-2033)
Figure 52. Middle East, Africa, and Latin America Biotechnological Drugs Market Share by Country (2018-2033)
Figure 53. Brazil Biotechnological Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 54. Mexico Biotechnological Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 55. Turkey Biotechnological Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 56. Saudi Arabia Biotechnological Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 57. Israel Biotechnological Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 58. GCC Countries Biotechnological Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 59. 3SBIO Revenue Growth Rate in Biotechnological Drugs Business (2018-2023)
Figure 60. Anhui Anke Biotechnology Revenue Growth Rate in Biotechnological Drugs Business (2018-2023)
Figure 61. Beijing SL Pharmaceutical Revenue Growth Rate in Biotechnological Drugs Business (2018-2023)
Figure 62. Biotech Pharmaceutical Revenue Growth Rate in Biotechnological Drugs Business (2018-2023)
Figure 63. Cadila Healthcare Revenue Growth Rate in Biotechnological Drugs Business (2018-2023)
Figure 64. Celgen Biopharma Revenue Growth Rate in Biotechnological Drugs Business (2018-2023)
Figure 65. Celltrion Revenue Growth Rate in Biotechnological Drugs Business (2018-2023)
Figure 66. Dr Reddy’s Revenue Growth Rate in Biotechnological Drugs Business (2018-2023)
Figure 67. GeneScience Pharmaceuticals Revenue Growth Rate in Biotechnological Drugs Business (2018-2023)
Figure 68. Hisun Pharma Revenue Growth Rate in Biotechnological Drugs Business (2018-2023)
Figure 69. Jiangsu Sihuan Bioengineering Revenue Growth Rate in Biotechnological Drugs Business (2018-2023)
Figure 70. Novartis (Sandoz) Revenue Growth Rate in Biotechnological Drugs Business (2018-2023)
Figure 71. Pfizer (Hospira) Revenue Growth Rate in Biotechnological Drugs Business (2018-2023)
Figure 72. Shanghai Lansheng Guojian Pharmaceutical Revenue Growth Rate in Biotechnological Drugs Business (2018-2023)
Figure 73. Shenzhen Neptunus Interlong Bio-Technique Revenue Growth Rate in Biotechnological Drugs Business (2018-2023)
Figure 74. Tonghua Dongbao Pharmaceutical Revenue Growth Rate in Biotechnological Drugs Business (2018-2023)
Figure 75. Torrent Pharmaceuticals Revenue Growth Rate in Biotechnological Drugs Business (2018-2023)
Figure 76. Bottom-up and Top-down Approaches for This Report
Figure 77. Data Triangulation
Figure 78. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries